HEARTBEAM INC (BEAT)

US42238H1086 - Common Stock

2.78  -0.04 (-1.42%)

After market: 2.78 0 (0%)

Fundamental Rating

3

Taking everything into account, BEAT scores 3 out of 10 in our fundamental rating. BEAT was compared to 192 industry peers in the Health Care Equipment & Supplies industry. BEAT has a great financial health rating, but its profitability evaluates not so good. BEAT has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

BEAT had negative earnings in the past year.
BEAT had a negative operating cash flow in the past year.
In the past 5 years BEAT always reported negative net income.
In the past 5 years BEAT always reported negative operating cash flow.

1.2 Ratios

BEAT has a Return On Assets of -110.78%. This is amonst the worse of the industry: BEAT underperforms 83.33% of its industry peers.
Looking at the Return On Equity, with a value of -120.47%, BEAT is doing worse than 74.48% of the companies in the same industry.
Industry RankSector Rank
ROA -110.78%
ROE -120.47%
ROIC N/A
ROA(3y)-145.96%
ROA(5y)-1595.58%
ROE(3y)-223.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BEAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

The number of shares outstanding for BEAT has been increased compared to 1 year ago.
Compared to 5 years ago, BEAT has less shares outstanding
There is no outstanding debt for BEAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

BEAT has an Altman-Z score of 33.57. This indicates that BEAT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 33.57, BEAT belongs to the top of the industry, outperforming 97.40% of the companies in the same industry.
BEAT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 33.57
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 12.07 indicates that BEAT has no problem at all paying its short term obligations.
BEAT has a Current ratio of 12.07. This is amongst the best in the industry. BEAT outperforms 94.27% of its industry peers.
A Quick Ratio of 12.07 indicates that BEAT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 12.07, BEAT belongs to the best of the industry, outperforming 94.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 12.07
Quick Ratio 12.07

3

3. Growth

3.1 Past

BEAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.48%, which is quite impressive.
EPS 1Y (TTM)66.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

BEAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.81% yearly.
Based on estimates for the next years, BEAT will show a very strong growth in Revenue. The Revenue will grow by 564.02% on average per year.
EPS Next Y20.79%
EPS Next 2Y14.73%
EPS Next 3Y12.81%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y458.55%
Revenue Next 3Y564.02%
Revenue Next 5YN/A

3.3 Evolution

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BEAT. In the last year negative earnings were reported.
Also next year BEAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BEAT's earnings are expected to grow with 12.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.73%
EPS Next 3Y12.81%

0

5. Dividend

5.1 Amount

No dividends for BEAT!.
Industry RankSector Rank
Dividend Yield N/A

HEARTBEAM INC

NASDAQ:BEAT (5/31/2024, 7:25:27 PM)

After market: 2.78 0 (0%)

2.78

-0.04 (-1.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap73.20M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -110.78%
ROE -120.47%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 12.07
Quick Ratio 12.07
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)66.48%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y20.79%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y